Influence of cilnidipine or nisoldipine on sympathetic activity in healthy male subjects
- PMID: 18043999
- DOI: 10.1007/s00380-007-0984-y
Influence of cilnidipine or nisoldipine on sympathetic activity in healthy male subjects
Abstract
The aim of this study was to investigate whether cilnidipine, an N- and L-type calcium channel blocker, and nisoldipine, an L-type calcium channel blocker, have different effects on sympathetic activity, using an identical group of healthy male subjects. Eight healthy men (22-28 years) were given 10 mg of cilnidipine or 10 mg of nisoldipine in a randomized crossover design. In each trial, in subjects without medication on day 1 (control) and with medication on day 2, we measured heart rate (HR), low frequency (LF)/high frequency (HF) of HR variability, and plasma noradrenaline (NA) in a resting supine position and during head-up tilt, and palmar sweating during a mental arithmetic test, before and at 1, 2, 4, 6, and 8 h after administration. Time-plasma concentration profiles of the two drugs were similar. Measurements in controls on the two days showed no significant difference in any of these parameters. Nisoldipine, but not cilnidipine, slightly increased HR and LF/HF at rest. Head-up tilt increased HR, LF/HF, and plasma NA. As evaluated with repeated-measures analysis of variance, head-up tilt induced a significant increase in LF/HF, but not HR or plasma NA, and the effect of cilnidipine was significantly less than that of nisoldipine (P = 0.017). Postural hypotension was not observed. There was no difference in mental arithmetic-induced sweating between the two drugs. Cilnidipine, but not nisoldipine, might have a weak inhibitory effect on reflex sympathetic activity.
Similar articles
-
L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.Blood Press. 2012 Dec;21(6):367-71. doi: 10.3109/08037051.2012.694200. Epub 2012 Jul 3. Blood Press. 2012. PMID: 22747420 Clinical Trial.
-
The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.Fundam Clin Pharmacol. 2004 Jun;18(3):309-19. doi: 10.1111/j.1472-8206.2004.00236.x. Fundam Clin Pharmacol. 2004. PMID: 15147282
-
Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.Hypertension. 1999 Jun;33(6):1447-52. doi: 10.1161/01.hyp.33.6.1447. Hypertension. 1999. PMID: 10373231 Clinical Trial.
-
Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis.BMC Cardiovasc Disord. 2019 Dec 30;19(1):320. doi: 10.1186/s12872-019-01298-y. BMC Cardiovasc Disord. 2019. PMID: 31888497 Free PMC article.
-
Nisoldipine.2017 Jan 11. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Jan 11. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643685 Free Books & Documents. Review.
Cited by
-
Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus.Drug Des Devel Ther. 2014 Jun 17;8:799-810. doi: 10.2147/DDDT.S47441. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24970998 Free PMC article.
-
N-type calcium channel and renal injury.Int Urol Nephrol. 2022 Nov;54(11):2871-2879. doi: 10.1007/s11255-022-03183-8. Epub 2022 Apr 13. Int Urol Nephrol. 2022. PMID: 35416563 Free PMC article. Review.
-
Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.Clin Exp Pharmacol Physiol. 2015 Apr;42(4):344-52. doi: 10.1111/1440-1681.12360. Clin Exp Pharmacol Physiol. 2015. PMID: 25582553 Free PMC article.
-
Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease.Heart Vessels. 2009 Jul;24(4):301-7. doi: 10.1007/s00380-008-1125-y. Epub 2009 Jul 22. Heart Vessels. 2009. PMID: 19626404
-
Comparative effects of valsartan in combination with cilnidipine or amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats.Hypertens Res. 2015 Jan;38(1):39-47. doi: 10.1038/hr.2014.136. Epub 2014 Sep 11. Hypertens Res. 2015. PMID: 25209105
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous